Intercept Pharmaceuticals, Inc. - stock earnings
Stock symbol ICPT is outdated, potentially delisted? Maybe it is available on other exchange?
ICPT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 25, 2024 AfterMarket | - / 0.1973000000 | - | - / 83.8 million | - |
ICPT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -32.1 million USD | 68.0 million USD |
| 2022Q4 | -20.8 million USD | 77.2 million USD |
| 2022Q3 | 267.5 million USD | 77.6 million USD |
| 2022Q2 | -7.5 million USD | 71.8 million USD |
| 2022Q1 | -17.3 million USD | 59.1 million USD |
| 2021Q4 | -36.3 million USD | 92.4 million USD |
| 2021Q3 | -3.6 million USD | 92.8 million USD |
| 2021Q2 | -11.1 million USD | 96.6 million USD |
| 2021Q1 | -40.4 million USD | 81.7 million USD |
| 2020Q4 | -52.1 million USD | 83.3 million USD |
ICPT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 221.8 million USD | 285.7 million USD |
| 2021 | -91.4 million USD | 363.5 million USD |
| 2020 | -274.9 million USD | 312.7 million USD |
| 2019 | -344.7 million USD | 252.0 million USD |
| 2018 | -309.2 million USD | 179.8 million USD |
| 2017 | -360.4 million USD | 131.0 million USD |
ICPT
Price: $19
52 week price:
Earnings Per Share: 2.14 USD
P/E Ratio: -5.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 819401
Ebitda: -103.8 millionMarket Capitalization: 794.7 million